Medicines authorised in Romania

Leqvio

Leqvio is a medicine containing Inclisiran, listed in the Romanian national register of medicines for human use with 2 presentations.

General information from the official register, not medical advice. Anpheros does not diagnose and does not recommend medicines. Read the package leaflet and ask your doctor or pharmacist before taking any medicine.

At a glance

Active substance
INCLISIRAN
ATC code
C10AX16 Cardiovascular system
Therapeutic action
HIPOCOLESTEROLEMIANTE SI HIPOTRIGLICERIDEMIANTE ALTE HIPOCOLESTEROLEMIANTE SI HIPOTRIGLICERIDEMIANTE
Prescription
Prescription required (register code PRF)
Marketing authorisation holder
NOVARTIS EUROPHARM LIMITED - IRLANDA
Manufacturer
NOVARTIS PHARMACEUTICAL MANUFACTURING GMBH - AUSTRIA
Pharmaceutical form
SOL. INJ.

Presentations and codes

CIM is the code of each pack in the Romanian register; the Anpheros app saves it when it recognises the box.

CIM codeFormStrengthPackPrescriptionAuthorisationShelf life
W67346001SOL. INJ.189 mg/mlCutie cu o seringa preumpluta din sticla cu ac si protectie rigida pentru ac x 1,5 ml solutiePRF1494/2020/013 ani
W67346002SOL. INJ.189 mg/mlCutie cu o seringa preumpluta din sticla cu ac si protectie rigida pentru ac, cu protectie suplimentara pentru ac x 1,5 ml solutiePRF1494/2020/023 ani

What it is used for

Anpheros does not have a page with official indications for this substance yet.

The package leaflet and the summary of product characteristics are published by ANMDMR: search for “Leqvio” in the national register.

Scan the box in Anpheros

In the Anpheros Daily app, photograph the medicine box: the app reads the name and strength, matches them against this register and adds the medicine to your list, with its code. From your list you can come back to this page.

Get the app

Source: ANMDMR — National Agency for Medicines and Medical Devices of Romania, Nomenclatorul medicamentelor de uz uman (register updated 29 October 2026). Shown as published, in Romanian where the register is in Romanian.